Conditions

Ductal Carcinoma in Situ treatment includes surgery, radiation, and sometimes hormone therapy, depending on individual patient factors and risk.

Triple-negative breast cancer lacks estrogen, progesterone, and HER2 receptors, making it harder to treat with standard therapies.

Invasive ductal carcinoma treatment includes surgery, chemotherapy, radiation, hormone therapy, and targeted therapies based on tumor characteristics and stage.

HER2-positive breast cancer is a type of breast cancer characterized by the overexpression of the

Invasive Lobular Carcinoma (ILC) is the second most common type of breast cancer, originating in

Inflammatory Breast Cancer (IBC) is a rare yet aggressive form of breast cancer that requires